AlloDerm Versus Cortiva: A Multicenter Pooled Analysis of Clinical and Economic Outcomes in Breast Reconstruction
Current evidence shows no clear difference between AlloDerm and Cortiva in terms of clinical outcomes but identifies a potential cost advantage for Cortiva. Pending long-term data, Cortiva represents the more economical choice.
Authors
- Liam D. Cato
- Joshua Wang (ORCID: https://orcid.org/0000-0001-8967-8296)
- Peyton Harris (ORCID: https://orcid.org/0009-0008-0563-9782)
- Sarya Swed
- Grace Gasper (ORCID: https://orcid.org/0009-0008-4636-8739)
- Samantha Cervantes Valadez
- Keyvon Rashidi
- Peter Zak
- Philong Nguyen (ORCID: https://orcid.org/0009-0002-4259-4129)
Institutions
- University of Aleppo (SY)
- Cornell University (US)
- Methodist Hospital (US)
- The University of Texas Medical Branch at Galveston (US)
- Bryan College (US)
Publication Details
- Journal
- Plastic & Reconstructive Surgery Global Open
- Published
- 2026-02-01
- DOI
- https://doi.org/10.1097/gox.0000000000007442
- Primary Topic
- Breast Implant and Reconstruction
- Type
- article
- Field-Weighted Citation Impact
- 0.00